This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

(1) Inhibit plasminogen activator, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promote the release of active substances by platelets, enhance platelet aggregation and adhesion. Shorten the coagulation time and produce a hemostatic effect. (3) Enhance capillary resistance and reduce capillary permeability, thereby reducing bleeding.

This product can inhibit the occurrence of cachexia in tumor-bearing mice, inhibit the growth of cancer cells, and prolong the survival time of tumor-bearing mice by more than double. This product can inhibit the production of cachectin in tumor cells, and also inhibit the effect of cachectin on normal cells, thereby preventing cachexia in tumor patients.

This product has the effect of resisting platelet aggregation and disaggregating aggregated platelets. In addition, it can dilate arterioles, improve microcirculation and increase cerebral blood flow, thus producing the effects of anti-thrombosis and thrombolysis.

This product is an acidic polysaccharide drug with strong dispersing and emulsifying properties, improving the viscoelasticity of blood rheology; it can inactivate thrombin, and its anticoagulant effect is equivalent to 1/3 to 1/2 of heparin; it prevents platelet adhesion to collagen and inhibits platelet aggregation; it has prostaglandin (PGI2)-like effects such as anti-thrombotic, lowering blood viscosity, micro-arteriovenous spasm, and red blood cell and platelet depolymerization; it significantly lowers blood lipids, cholesterol, triglycerides, low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL), while increasing high-density lipoprotein (HDL) levels; it inhibits the occurrence and development of atherosclerotic lesions; it dilates peripheral blood vessels, improves microcirculation, and inhibits thrombosis in arteries and veins; it has multiple functions such as lowering blood sugar and blood pressure.